Israel Englander Stealth Bio Therapeutics Corp Transaction History

Millennium Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.71 $532 - $2,100	2,958 Added 7.67%	41,517 $10,000
Q1 2022 May 16, 2022	SELL	$0.49 - $0.9 $755 - $1,387	-1,542 Reduced 3.85%	38,559 $27,000
Q4 2021 Feb 14, 2022	BUY	$0.76 - $1.48 $3,190 - $6,213	4,198 Added 11.69%	40,101 $33,000
Q3 2021 Nov 15, 2021	BUY	$1.17 - $1.58 $42,006 - $56,726	35,903 New	35,903 $49,000
Q3 2020 Nov 16, 2020	SELL	$1.32 - $2.23 $29,005 - $49,002	-21,974 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.23 - $2.22 $17,288 - $31,204	-14,056 Reduced 39.01%	21,974 $40,000
Q1 2020 May 14, 2020	BUY	$0.97 - $3.13 $34,949 - $112,773	36,030 New	36,030 $45,000
Q4 2019 Feb 14, 2020	SELL	$3.26 - $13.7 $86,184 - $362,186	-26,437 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.22 - $13.36 $48,895 - $125,143	-9,367 Reduced 26.16%	26,437 $158,000
Q2 2019 Aug 15, 2019	SELL	$11.67 - $15.45 $9.74 Million - $12.9 Million	-834,218 Reduced 95.88%	35,804 $434,000
Q2 2019 Aug 14, 2019	BUY	$11.67 - $15.45 $9.55 Million - $12.6 Million	818,094 Added 1575.44%	870,022 $5.33 Million
Q1 2019 May 14, 2019	BUY	$11.75 - $18.01 $610,154 - $935,223	51,928 New	51,928 $666,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.